BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
39 results:

  • 1. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
    Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
    Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
    Infante MS; Nemirovsky D; Devlin S; DeWolf S; Tamari R; Dahi PB; Lee YJ; Chung DJ; Politikos I; Barker J; Giralt SA; Babady NE; Ramanathan L; Papanicolaou GA; Seo S; Kamboj M; Perales MA; Shah GL
    Transplant Cell Ther; 2024 Jan; 30(1):116.e1-116.e12. PubMed ID: 37806446
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-world evidence of the safety and survival with CD19 car-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
    McKenna M; Epperla N; Ghobadi A; Liu J; Lazaryan A; Ibrahim U; Jacobson CA; Naik SG; Nastoupil L; Chowdhury SM; Voorhees TJ; Jacobs MT; Farooq U; Osman K; Olszewski AJ; Ahmed S; Evens AM
    Br J Haematol; 2023 Jul; 202(2):248-255. PubMed ID: 37129856
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Severe cytopenia after CD19 car T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
    Penack O; Peczynski C; Koenecke C; Polge E; Kuhnl A; Fegueux N; Daskalakis M; Kröger N; Dreger P; Besley C; Schanz U; Bloor A; Ganser A; Forcade E; Corral LL; Passweg JR; Novak U; Moiseev I; Schoemans H; Basak GW; Chabannon C; Sureda A; Averbuch D; Glass B; de la Camara R; Peric Z
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072350
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed car T-cell therapy: an EPICOVIDEHA survey.
    van Doesum JA; Salmanton-García J; Marchesi F; Di Blasi R; Falces-Romero I; Cabirta A; Farina F; Besson C; Weinbergerová B; Van Praet J; Schönlein M; López-García A; Lamure S; Guidetti A; De Ramón-Sánchez C; Batinić J; Gavriilaki E; Tragiannidis A; Tisi MC; Plantefeve G; Petzer V; Ormazabal-Vélez I; Marques de Almeida J; Marchetti M; Maertens J; Machado M; Kulasekararaj A; Hernández-Rivas JÁ; Gomes da Silva M; Fernández N; Espigado I; Drgoňa Ľ; Dragonetti G; Metafuni E; Calbacho M; Blennow O; Wolf D; van Anrooij B; Nunes Rodrigues R; Nordlander A; Martín-González JA; Liévin R; Jiménez M; Gräfe SK; García-Sanz R; Córdoba R; Rahimli L; van Meerten T; Cornely OA; Pagano L
    Blood Adv; 2023 Jun; 7(11):2645-2655. PubMed ID: 37058479
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.
    Saleh K; Arbab A; Ghez D; Bigenwald C; Cotteret S; Marzac C; Pasquier F; Pilorge S; Saada V; Vergé V; Ribrag V; Castilla-Llorente C
    Immunotherapy; 2023 Apr; 15(6):401-407. PubMed ID: 36950962
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An adolescent case of sellar osteochondromyxoma in the setting of spondyloepiphyseal dysplasia.
    Peng S; Behbahani M; Sharma S; Wadhwani NR; Rastatter JC; Alden TD
    Childs Nerv Syst; 2023 Apr; 39(4):1083-1087. PubMed ID: 36723686
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Follicular lymphoma: 2023 update on diagnosis and management.
    Jacobsen E
    Am J Hematol; 2022 Dec; 97(12):1638-1651. PubMed ID: 36255040
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Waldenström disease: News and perspectives in 2022].
    Bouclet F; Krzisch D; Leblond V; Tomowiak C; Laribi K; Ysebaert L; Tournilhac O; Dartigeas C; Leprêtre S; Jondreville L;
    Bull Cancer; 2023 Jan; 110(1):88-100. PubMed ID: 36229266
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Minimal/Measurable Disease Analysis in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Flow Cytometry.
    Gao Q; Roshal M
    Curr Protoc; 2022 Aug; 2(8):e503. PubMed ID: 35980134
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
    Trad R; Warda W; Alcazer V; Neto da Rocha M; Berceanu A; Nicod C; Haderbache R; Roussel X; Desbrosses Y; Daguindau E; Renosi F; Roumier C; Bouquet L; Biichle S; Guiot M; Seffar E; Caillot D; Depil S; Robinet E; Salma Y; Deconinck E; Deschamps M; Ferrand C
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35803613
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (car-T) Therapy.
    Ahmed N; Kumar A; Kharfan-Dabaja MA; DeFilipp Z; Herrera A; Hashmi S; Dholaria B; Perales MA; Carpenter PA; Hamadani M
    Transplant Cell Ther; 2022 Sep; 28(9):523-529. PubMed ID: 35671986
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.
    Bueno C; Barrera S; Bataller A; Ortiz-Maldonado V; Elliot N; O'Byrne S; Wang G; Rovira M; Gutierrez-Agüera F; Trincado JL; González-González M; Morgades M; Sorigué M; Bárcena P; Zanetti SR; Torrebadell M; Vega-Garcia N; Rives S; Mallo M; Sole F; Mead AJ; Roberts I; Thongjuea S; Psaila B; Juan M; Delgado J; Urbano-Ispizúa A; Ribera JM; Orfao A; Roy A; Menendez P
    Blood; 2022 Jul; 140(1):38-44. PubMed ID: 35421218
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Management of neurotoxicity following car-T cell therapy: Recommendations of the SFGM-TC].
    Picard M; Sterin A; Bay JO; Courbon C; Moreau AS; Paul F; Pochon C; Tudesq JJ; Vicente C; Yakoub-Agha M; Yakoub-Agha I
    Bull Cancer; 2023 Feb; 110(2S):S123-S131. PubMed ID: 35094839
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Management of cytokine release syndrome and macrophage activation syndrome following car-T cell therapy: Guidelines from the SFGM-TC].
    Tudesq JJ; Yakoub-Agha M; Bay JO; Courbon C; Paul F; Picard M; Pochon C; Sterin A; Vicente C; Canet E; Yakoub-Agha I; Moreau AS
    Bull Cancer; 2023 Feb; 110(2S):S116-S122. PubMed ID: 34895696
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of variant APL translocations prkar1a-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.
    King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
    Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific car T-cell therapy.
    Hines MR; Keenan C; Maron Alfaro G; Cheng C; Zhou Y; Sharma A; Hurley C; Nichols KE; Gottschalk S; Triplett BM; Talleur AC
    Br J Haematol; 2021 Aug; 194(4):701-707. PubMed ID: 34263927
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increased frequency of TIGIT
    Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
    Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cryopreservation of sperm before gonadotoxic treatment at the University Hospital Brno in the years 1995-2020.
    Ventruba Pavel; Žáková Jana; Ješeta Michal; Crha Igor; Lousová Eva; Huser Martin; Hudeček Robert
    Ceska Gynekol; 2021; 86(3):156-162. PubMed ID: 34167307
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.